These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Pioglitazone treatment restores in vivo muscle oxidative capacity in a rat model of diabetes. Wessels B; Ciapaite J; van den Broek NM; Houten SM; Nicolay K; Prompers JJ Diabetes Obes Metab; 2015 Jan; 17(1):52-60. PubMed ID: 25200673 [TBL] [Abstract][Full Text] [Related]
11. Captopril enhanced insulin-stimulated glycogen synthesis in skeletal muscle but not fatty acid synthesis in adipose tissue of hereditary hypertriglyceridemic rats. Cahová M; Vavrinková H; Tutterova M; Meschisvilli E; Kazdova L Metabolism; 2003 Nov; 52(11):1406-12. PubMed ID: 14624398 [TBL] [Abstract][Full Text] [Related]
12. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422 [TBL] [Abstract][Full Text] [Related]
13. The impaired response of non-obese hereditary hypertriglyceridemic rats to glucose load is associated with low glucose storage in energy reserves. Cahova M; Vavrinkova H; Meschisvilli E; Markova I; Kazdova L Exp Clin Endocrinol Diabetes; 2004 Nov; 112(10):549-55. PubMed ID: 15578328 [TBL] [Abstract][Full Text] [Related]
14. An increase in peroxisomal fatty acid oxidation is not sufficient to prevent tissue lipid accumulation in hHTg rats. Ukropec J; Klimes I; Gasperíková D; Demcáková E; Drevon CA; Reseland JE; Seböková E Ann N Y Acad Sci; 2002 Jun; 967():71-9. PubMed ID: 12079837 [TBL] [Abstract][Full Text] [Related]
15. Modulation of tissue fatty acids by L-carnitine attenuates metabolic syndrome in diet-induced obese rats. Panchal SK; Poudyal H; Ward LC; Waanders J; Brown L Food Funct; 2015 Aug; 6(8):2496-506. PubMed ID: 26190559 [TBL] [Abstract][Full Text] [Related]
16. Improvement in the expression of hepatic genes involved in fatty acid metabolism in obese rats supplemented with taurine. Bonfleur ML; Borck PC; Ribeiro RA; Caetano LC; Soares GM; Carneiro EM; Balbo SL Life Sci; 2015 Aug; 135():15-21. PubMed ID: 26092479 [TBL] [Abstract][Full Text] [Related]
17. The impact of altered carnitine availability on acylcarnitine metabolism, energy expenditure and glucose tolerance in diet-induced obese mice. Schooneman MG; Houtkooper RH; Hollak CE; Wanders RJ; Vaz FM; Soeters MR; Houten SM Biochim Biophys Acta; 2016 Aug; 1862(8):1375-82. PubMed ID: 27112275 [TBL] [Abstract][Full Text] [Related]
18. Insulin resistance in the hereditary hypertriglyceridemic rat is associated with an impairment of delta-6 desaturase expression in liver. Gasperíková D; Demcáková E; Ukropec J; Klimes I; Seböková E Ann N Y Acad Sci; 2002 Jun; 967():446-53. PubMed ID: 12079873 [TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of troxerutin on metabolic disorders in non-obese model of metabolic syndrome. Malinska H; Hüttl M; Oliyarnyk O; Markova I; Poruba M; Racova Z; Kazdova L; Vecera R PLoS One; 2019; 14(8):e0220377. PubMed ID: 31404079 [TBL] [Abstract][Full Text] [Related]
20. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease. Kathirvel E; Morgan K; French SW; Morgan TR Nutr Res; 2013 Nov; 33(11):932-41. PubMed ID: 24176233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]